RTC Innovation

Oxford Enhanced Medical Limited

RTC Innovation sourced the £1m investment required for Oxford University’s electro-magnetic acoustic imaging spin-out, Oxford Enhanced Medical, Limited (OxEML). The spin-out aims to improve the early diagnosis of cancers by developing imaging technology with a resolution comparable to (expensive) MRI, but with the accessibility and affordability of ultrasound.

Finding a single private investor for the project with a strategic background in medical products, RTC Innovation worked closely with Isis Innovation to create the spin-out in October 2015. Clinical trials are due to take place in Canada.